|
1
|
Park JW, Park DM, Choi BK, Kwon BS, Seong
JK, Green JE, Kim DY and Kim HK: Establishment and characterization
of metastatic gastric cancer cell lines from murine gastric
adenocarcinoma lacking Smad4, p53, and E-cadherin. Mol Carcinog.
54:1521–1527. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang X, Qian Y, Wu H, Xie X, Zhou Q, Wang
Y, Kuang W, Shen L, Li K, Su J, et al: Aberrant expression of
osteopontin and E-cadherin indicates radiation resistance and poor
prognosis for patients with cervical carcinoma. J Histochem
Cytochem. 63:88–98. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Y, Chen XG and Liang CZ: Expressions
of E-cadherin and N-cadherin in prostate cancer and their
implications. Zhonghua Nan Ke Xue. 20:781–786. 2014.(In Chinese).
PubMed/NCBI
|
|
4
|
Slowinska-Klencka D, Sporny S,
Stasikowska-Kanicka O, Popowicz B and Klencki M: E-cadherin
expression is more associated with histopathological type of
thyroid cancer than with the metastatic potential of tumors. Folia
Histochem Cytobiol. 50:519–526. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dellaportas D, Koureas A, Contis J,
Lykoudis PM, Vraka I, Psychogios D, Kondi-Pafiti A and Voros DK:
Contrast-enhanced color Doppler ultrasonography for preoperative
evaluation of sentinel lymph node in breast cancer patients. Breast
Care (Basel). 10:331–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Biedka M, Makarewicz R, Marszałek A, Sir
J, Kardymowicz H and Goralewska A: Labeling of microvessel density,
lymphatic vessel density and potential role of proangiogenic and
lymphangiogenic factors as a predictive/prognostic factors after
radiotherapy in patients with cervical cancer. Eur J Gynaecol
Oncol. 33:399–405. 2012.PubMed/NCBI
|
|
7
|
Shiyan L, Pintong H, Zongmin W, Fuguang H,
Zhiqiang Z, Yan Y and Cosgrove D: The relationship between enhanced
intensity and microvessel density of gastric carcinoma using double
contrast-enhanced ultrasonography. Ultrasound Med Biol.
35:1086–1091. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y, Ye Z, Sun H and Bai R: Grading of
uterine cervical cancer by using the ADC difference value and its
correlation with microvascular density and vascular endothelial
growth factor. Eur Radiol. 23:757–765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakamura K, Joja I, Nagasaka T, Haruma T
and Hiramatsu Y: Maximum standardized lymph node uptake value could
be an important predictor of recurrence and survival in patients
with cervical cancer. Eur J Obstet Gynecol Reprod Biol. 173:77–82.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kamrava M: Potential role of ultrasound
imaging in interstitial image based cervical cancer brachytherapy.
J Contemp Brachytherapy. 6:223–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zaridah S: A review of cervical cancer
research in Malaysia. Med J Malaysia. 69 Suppl A:33–41.
2014.PubMed/NCBI
|
|
12
|
Benckert C, Thelen A, Cramer T, Weichert
W, Gaebelein G, Gessner R and Jonas S: Impact of microvessel
density on lymph node metastasis and survival after curative
resection of pancreatic cancer. Surg Today. 42:169–176. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang J, Shang X, Zhang H, Ma W, Xu Y,
Zhou Q, Gao Y, Yu S and Qi Y: Correlation between maximum intensity
and microvessel density for differentiation of malignant from
benign thyroid nodules on contrast-enhanced sonography. J
Ultrasound Med. 33:1257–1263. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang MX, Mulvana H, Gauthier T, Lim AK,
Cosgrove DO, Eckersley RJ and Stride E: Quantitative
contrast-enhanced ultrasound imaging: A review of sources of
variability. Interface Focus. 1:520–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li B, Shi H, Wang F, Hong D, Lv W, Xie X
and Cheng X: Expression of E-, P- and N-cadherin and its clinical
significance in cervical squamous cell carcinoma and precancerous
lesions. PLoS One. 11:e01559102016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng J, Qi S, Wang P, Li W, Song L, Liu C
and Li F: Meta-analysis of downregulated E-cadherin as a poor
prognostic biomarker for cervical cancer. Future Oncol. 24:102–104.
2015.
|
|
17
|
Wagih HM, El-Ageery SM and Alghaithy AA: A
study of RUNX3, E-cadherin and β-catenin in CagA-positive
Helicobacter pylori associated chronic gastritis in Saudi
patients. Eur Rev Med Pharmacol Sci. 19:1416–1429. 2015.PubMed/NCBI
|
|
18
|
Myong NH: Loss of E-cadherin and
acquisition of vimentin in epithelial-mesenchymal transition are
noble indicators of uterine cervix cancer progression. Korean J
Pathol. 46:341–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng Y, Zhou Y, Jiang W, Yang X, Zhu J,
Feng D, Wei Y, Li M, Yao F, Hu W, et al: Significance of
E-cadherin, β-catenin, and vimentin expression as postoperative
prognosis indicators in cervical squamous cell carcinoma. Hum
Pathol. 43:1213–1220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Do TV, Kubba LA, Du H, Sturgis CD and
Woodruff TK: Transforming growth factor-beta1, transforming growth
factor-beta2, and transforming growth factor-beta3 enhance ovarian
cancer metastatic potential by inducing a Smad3-dependent
epithelial-to-mesenchymal transition. Mol Cancer Res. 6:695–705.
2008. View Article : Google Scholar : PubMed/NCBI
|
